CDNA Earnings

CDNA reported its earnings on 2026-04-28, showcasing a revenue of against an estimate of 109.69M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.13 by 0%. The stock experienced a -5.07% price change on the earnings day and a -4.34% change over the next five days, reflecting market reactions to the results.

Following CDNA's earnings announcement on 2026-04-28, the stock price moved by -5.07% on the day of the release. Over the subsequent five days, it saw a -4.34% change. Historically, CDNA's stock price tends to shift by an average of -4.41% in the 10 days leading up to earnings and 6% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate CDNA's annual revenue to reach 103.72M, while the EPS is projected at 0.23. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CDNA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CDNA's stock price typically moves by -4.41% in the 10 days before its earnings and 6% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 0.23 and revenue of 103.72M.

The earnings call highlights strong financial growth for Naveris and a strategic focus on expanding testing and improving efficiency, which are positive indicators. The high attach rate for digital solutions at transplant centers and stable reimbursement rates further support a positive outlook. However, some uncertainties, such as the GYN indication timeline and lack of Naveris contribution to current revenue guidance, temper the sentiment slightly. Overall, the positive growth projections and market leadership in key areas suggest a likely positive stock price movement.